Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | FAAH | O00519 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.43 |
| ▸ | PPARG | P37231 | 3/20 | 0.38 |
| ▸ | CTSK | P43235 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.36 |
| ▸ | PPARA | Q07869 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2119927 | 0.88 | MEN1 (0.39) | MEN1FAAHMAPK1KMT2AALDH1A1 | |
| SCHEMBL15281945 | 0.82 | EPHX1 (0.42) | ALDH1A1EPHX1PPARGATM | |
| SCHEMBL2120079 | 0.81 | MEN1 (0.41) | MEN1FAAHMAPK1KMT2AALDH1A1 | |
| SCHEMBL7874828 | 0.80 | CA1 (0.48) | ALDH1A1MAPTATM | |
| SCHEMBL26319568 | 0.80 | MMP1 (0.39) | MEN1FAAHMAPK1KMT2AALDH1A1 | |
| SCHEMBL9323640 | 0.79 | ALDH1A1 (0.44) | MAPK1ALDH1A1ATM | |
| SCHEMBL2122733 | 0.78 | GAA (0.44) | MEN1KMT2AEPHX1MAPTHSD17B10 | |
| SCHEMBL9515904 | 0.78 | CA1 (0.47) | MAPK1ALDH1A1EPHX1MAPTHSD17B10 | |
| SCHEMBL446324 | 0.78 | CA1 (0.47) | MAPK1ALDH1A1EPHX1MAPTHSD17B10 | |
| SCHEMBL12309039 | 0.78 | CA1 (0.47) | MAPK1ALDH1A1EPHX1MAPTHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106047373-A | Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal element | JSR株式会社 | 2016-10-26 | — | — | CN | disclosed |
| CN-103045268-B | Crystal aligning agent, liquid crystal orienting film and liquid crystal display cells | JSR株式会社 | 2016-09-14 | — | — | CN | disclosed |
| CN-105874882-A | Display or illumination device, and method for forming insulating film | JSR株式会社 | 2016-08-17 | — | — | CN | disclosed |
| CN-103627406-B | Crystal aligning agent, liquid crystal orienting film and liquid crystal display cells | JSR株式会社 | 2016-08-17 | — | — | CN | disclosed |
| CN-103509563-B | Light orientation crystal aligning agent, liquid crystal orienting film and manufacture method, liquid crystal display cells, compound and polymer | JSR株式会社 | 2016-08-10 | — | — | CN | disclosed |
| US-8871894-B2 | Production method of polyhydroxyimide | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2014-10-28 | — | — | US | disclosed |
| US-20120094232-A1 | PRODUCTION METHOD OF POLYHYDROXYIMIDE | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2012-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120094232-A1 | PRODUCTION METHOD OF POLYHYDROXYIMIDE | GRHPR, MRPL21, F12 | MEN1 2948/4885FAAH 1572/4885MAPK1 4075/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.